ATLANTA, June 9, 2021 /PRNewswire/ — iResearch Atlanta welcomes new investigators and expands its operations to serve more patients in phase I-IV clinical trials, the ability to continue researching new and innovative therapies including COVID-19.
iResearch Atlanta, co-founded in 2010 by Heather Beitz, Chief Executive Officer and Sara Castle, Chief Operations Officer has recently grown its exceptional team of Investigators. With seven renowned, local physicians, iResearch Atlanta will continue as a KOL (Key Opinion Leader) in several therapeutic indications.
Led by Kimball A. Johnson, M.D., Medical Director, her team of Principal investigators and their specialties include:
Eric A. Awad, M.D.
Board Certified Neurology
Mary Burns, M.D.
Board Certified Psychiatry
Gayle L. Goldstein, M.D.,
Board Certified Ophthalmology
Saundra A. Maass-Robinson, M.D.,
Board Certified Psychiatry
Jessica C. McCoun, M.D.,
Board Certified Anesthesiology
Simone Whitmore, M.D.
Board Certified OBGYN
In addition, to the growing medical team, iResearch Atlanta is expanding its local footprint to include several locations in downtown Decatur, GA.
iResearch Atlanta is opening a new, 10,000 square foot clinical research unit! This innovation-inspired facility increases our Psychedelic and Consciousness Research and Phase I capabilities.
iResearch Atlanta remains committed to supporting our community and providing invaluable services to individuals experiencing a mental health crisis. In metro Atlanta and the state of Georgia, many people with serious mental illnesses do not have access to the support and treatment they need for sustainable recovery. iResearch Atlanta is proud to help patients recover from crisis and maintain their wellness.
iResearch Atlanta locations and capabilities below:
To learn more about our clinical research site, capabilities, and initiatives, visit the website at http://www.iResearchAtlanta.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/iresearch-atlanta-expands-clinical-research-options-after-covid-19-inspires-more-people-in-the-community-to-participate-301309472.html
SOURCE iResearch Atlanta
SAN DIEGO, CA / ACCESS Newswire / December 22, 2025 / CV Sciences, Inc. (OTCQB:CVSI)…
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…